1. Home
  2. BCRX vs TFIN Comparison

BCRX vs TFIN Comparison

Compare BCRX & TFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$7.89

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Triumph Financial Inc.

TFIN

Triumph Financial Inc.

HOLD

Current Price

$63.39

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
TFIN
Founded
1986
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
BCRX
TFIN
Price
$7.89
$63.39
Analyst Decision
Buy
Buy
Analyst Count
11
5
Target Price
$20.55
★ $75.40
AVG Volume (30 Days)
★ 4.7M
243.3K
Earning Date
11-04-2026
10-21-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 381.40
72.22
EPS
N/A
★ 1.19
Revenue
★ $25,186,000.00
N/A
Revenue This Year
N/A
$9.21
Revenue Next Year
$3.71
$10.34
P/E Ratio
★ N/A
$53.51
Revenue Growth
N/A
★ N/A
52 Week Low
$6.23
$49.27
52 Week High
$11.22
$83.52

Technical Indicators

Market Signals
Indicator
BCRX
TFIN
Relative Strength Index (RSI) 42.17 50.84
Support Level $6.35 $59.82
Resistance Level $9.22 $63.67
Average True Range (ATR) 0.30 1.78
MACD 0.00 0.50
Stochastic Oscillator 33.49 79.83

Price Performance

Historical Comparison
BCRX
TFIN

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company based in the United States. Along with its subsidiaries, the company operates in four reportable segments: Banking, Factoring, Payments, and Intelligence. The Banking segment, which generates maximum revenue, includes the operations of TBK Bank, offering traditional banking services. The Factoring segment provides working capital solutions to the trucking industry through the purchase of invoices generated by carriers at a discount. The Payments segment provides payment, audit, and other banking services for the over-the-road trucking industry, and the Intelligence segment operates to turn the over-the-road trucking data collected through the services offered into actionable insights for its customers.

Share on Social Networks: